• R & D
  • About RemeGen
  • Rongchang News
  • Media Report
  • Announcement
  • All-round upgrade and expansion of industry chain

    Established in March 1993, Rongchang has grown into a modern pharmaceutical enterprise integrating the R&D, production and sales of modern Chinese medicine and biological drugs. Currently, the company has multiple subsidiaries, including Rongchang Pharmaceuticals (Zibo), Ltd., Beijing Rongchang Medicine R&D Institute, Yantai Lida Pharmaceutical Co., Ltd.,RemeGen, Ltd. and MabPlex International Ltd.

    Challenge the impossible

    We constantly conduct innovative R&D in terms of technology,
    products and services.
    Caring for life and health is the endless source for our progress.

    To be the best pharma in China

    We are dedicated in various fields of diseases such as anorectal,
    neurology, autoimmunity, tumor and
    making efforts to become the best pharmaceutical company in China.